PULMONARY PHARMACOLOGY & THERAPEUTICS

Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.

Update on the clinical development of gefapixant, a P2X3 receptor antagonist for the treatment of refractory chronic cough.

Real-life rapidity of benralizumab effects in patients with severe allergic eosinophilic asthma: Assessment of blood eosinophils, symptom control, lung function and oral corticosteroid intake after the first drug dose.

The anti-proliferative effects of adiponectin on human lung adenocarcinoma A549\u202fcells and oxidative stress involvement.

Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations.

Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.

Heterogeneity of cough neurobiology: Clinical implications.

Effect of mesenchymal stromal (stem) cell (MSC) transplantation in asthmatic animal models: A systematic review and meta-analysis.

Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials.

Prevalence of Arnold nerve reflex in subjects with and without chronic cough: Relevance to Cough Hypersensitivity Syndrome.

SUMOylation of Vps34 by SUMO1 promotes phenotypic switching of vascular smooth muscle cells by activating autophagy in pulmonary arterial hypertension.

Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways.

Chronic cough in the elderly.

Dual role of autophagy/mitophagy in chronic obstructive pulmonary disease.

Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis.

Lung cancer in patients with Idiopathic Pulmonary Fibrosis. A retrospective multicenter study in Greece.

Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.

The role of increased red cell distribution width as a negative prognostic marker in patients with COPD.

Impact of Azathioprine use in chronic hypersensitivity pneumonitis patients.

Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.

The effect of erdosteine on airway defence mechanisms and inflammatory cytokines in the settings of allergic inflammation.

Non-pharmacological interventions for chronic cough: The past, present and future.

Comparison of anti-inflammatory mechanisms between doxofylline and theophylline in human monocytes.

Why chronic cough in children is different.

Limitations of the results from randomized clinical trials involving intravenous and nebulised magnesium sulphate in adults with severe acute asthma.

Choice of antifibrotic medication and disease severity predict weight loss in idiopathic pulmonary fibrosis.

Emerging targets for cough therapies; NK1 receptor antagonists.

Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes.

Are neural pathways processing airway inputs sensitized in patients with cough hypersensitivity?

Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors.

Adrenomedullin mediates pro-angiogenic and pro-inflammatory cytokines in asthma and COPD.

Efficacy of once-daily tiotropium Respimat in adults with asthma at GINA Steps 2-5.

Utility of open surgical lung biopsy in children.

Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.

Bronchiectasis and cough: An old relationship in need of renewed attention

Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.

Quantifying test-retest variability of natural and suppressed citric acid cough thresholds and urge to cough ratings.

Bronchoscopic delivery of aminocaproic acid as a treatment for pulmonary bleeding: A case series.

Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands.

Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India.

Low penetrance of antibiotics in the epithelial lining fluid. Experience from the use of inhaled antibiotics in patients with non CF-bronchiectasis.

A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.

The leukotriene receptor antagonist Montelukast can induce adverse skin reactions in asthmatic patients.

Outcomes of fibrinolytic therapy for patients with metastatic cancer and acute pulmonary embolism.

Alteplase and DNase for the treatment of pleural empyema in rats.

Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients.

Penehyclidine effects the angiogenic potential of pulmonary microvascular endothelial cells.